| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |